| . | CKD III–V (n = 2466) . | CKD III (n = 618) . | CKD IV (n = 1507) . | CKD V (n = 341) . |
|---|---|---|---|---|
| UA (SD) (mg/dL) | 7.81 (1.98) | 7.68 (1.95) | 7.94 (1.97) | 7.47 (2.02) |
| Age (SD) (years) | 68.98 (13.59) | 67.39 (13.67) | 69.85 (13.32) | 68.00 (14.28) |
| Sex (% male) | 65.4 | 27.3 | 36.1 | 41.1 |
| PKD | ||||
| % Diabetes | 17.7 | 15.7 | 18.8 | 16.4 |
| % Glomerulonephritis | 10.2 | 9.9 | 9.6 | 13.5 |
| % Nephrosclerosis | 16.3 | 16.5 | 18.7 | 5.6 |
| % Other | 11.8 | 11.3 | 11.3 | 15.0 |
| BMI (SD) (kg/m2) | 28.13 (5.64) | 28.67 (5.61) | 28.00 (5.53) | 27.76 (6.14) |
| eGFR* (SD) (MDRD) | 24.95 (9.80) | 38.18 (7.19) | 22.50 (4.21) | 11.78 (2.38) |
| MAP† (SD) (mm Hg) | 97.27 (12.70) | 95.75 (12.44) | 97.31 (12.67) | 99.87 (12.96) |
| Protein-restricted diet (%) | 4.7 | 0.8 | 4.0 | 14.4 |
| Diuretics use (%) | 72.5 | 66.8 | 75.0 | 71.7 |
| Statin use (%) | 50.2 | 57.7 | 48.4 | 44.2 |
| UA lowering drugs (%) | 39.3 | 40.5 | 39.6 | 36.1 |
| Diabetes Mellitus (%) | 36.0 | 36.4 | 36.9 | 31.1 |
| Arrhythmia (%) | 19.3 | 22.3 | 19.4 | 13.2 |
| CVD (%) | 14.5 | 16.3 | 13.7 | 15.0 |
| IHD (%) | 26.0 | 26.5 | 26.4 | 23.5 |
| Hypertension (%) | 72.9 | 77.8 | 71.4 | 70.7 |
| Pulmonary disease (%) | 11.4 | 13.9 | 10.7 | 10.0 |
| CHF (%) | 21.2 | 22.3 | 21.9 | 15.8 |
| Gout (%) | 10.0 | 11.5 | 10.2 | 6.5 |
| RRT initiation (n) | 530 | 21 | 324 | 190 |
| RRT modality | ||||
| %HD | 311 | 10 | 192 | 109 |
| %PD | 175 | 7 | 97 | 71 |
| %Tx | 44 | 4 | 30 | 10 |
| . | CKD III–V (n = 2466) . | CKD III (n = 618) . | CKD IV (n = 1507) . | CKD V (n = 341) . |
|---|---|---|---|---|
| UA (SD) (mg/dL) | 7.81 (1.98) | 7.68 (1.95) | 7.94 (1.97) | 7.47 (2.02) |
| Age (SD) (years) | 68.98 (13.59) | 67.39 (13.67) | 69.85 (13.32) | 68.00 (14.28) |
| Sex (% male) | 65.4 | 27.3 | 36.1 | 41.1 |
| PKD | ||||
| % Diabetes | 17.7 | 15.7 | 18.8 | 16.4 |
| % Glomerulonephritis | 10.2 | 9.9 | 9.6 | 13.5 |
| % Nephrosclerosis | 16.3 | 16.5 | 18.7 | 5.6 |
| % Other | 11.8 | 11.3 | 11.3 | 15.0 |
| BMI (SD) (kg/m2) | 28.13 (5.64) | 28.67 (5.61) | 28.00 (5.53) | 27.76 (6.14) |
| eGFR* (SD) (MDRD) | 24.95 (9.80) | 38.18 (7.19) | 22.50 (4.21) | 11.78 (2.38) |
| MAP† (SD) (mm Hg) | 97.27 (12.70) | 95.75 (12.44) | 97.31 (12.67) | 99.87 (12.96) |
| Protein-restricted diet (%) | 4.7 | 0.8 | 4.0 | 14.4 |
| Diuretics use (%) | 72.5 | 66.8 | 75.0 | 71.7 |
| Statin use (%) | 50.2 | 57.7 | 48.4 | 44.2 |
| UA lowering drugs (%) | 39.3 | 40.5 | 39.6 | 36.1 |
| Diabetes Mellitus (%) | 36.0 | 36.4 | 36.9 | 31.1 |
| Arrhythmia (%) | 19.3 | 22.3 | 19.4 | 13.2 |
| CVD (%) | 14.5 | 16.3 | 13.7 | 15.0 |
| IHD (%) | 26.0 | 26.5 | 26.4 | 23.5 |
| Hypertension (%) | 72.9 | 77.8 | 71.4 | 70.7 |
| Pulmonary disease (%) | 11.4 | 13.9 | 10.7 | 10.0 |
| CHF (%) | 21.2 | 22.3 | 21.9 | 15.8 |
| Gout (%) | 10.0 | 11.5 | 10.2 | 6.5 |
| RRT initiation (n) | 530 | 21 | 324 | 190 |
| RRT modality | ||||
| %HD | 311 | 10 | 192 | 109 |
| %PD | 175 | 7 | 97 | 71 |
| %Tx | 44 | 4 | 30 | 10 |
PKD, primary kidney disease.
*In ml/min/1.73 m2.
†Calculated as [(2/3*Systolic blood pressure) + (1/3*diastolic blood pressure)/2].
| . | CKD III–V (n = 2466) . | CKD III (n = 618) . | CKD IV (n = 1507) . | CKD V (n = 341) . |
|---|---|---|---|---|
| UA (SD) (mg/dL) | 7.81 (1.98) | 7.68 (1.95) | 7.94 (1.97) | 7.47 (2.02) |
| Age (SD) (years) | 68.98 (13.59) | 67.39 (13.67) | 69.85 (13.32) | 68.00 (14.28) |
| Sex (% male) | 65.4 | 27.3 | 36.1 | 41.1 |
| PKD | ||||
| % Diabetes | 17.7 | 15.7 | 18.8 | 16.4 |
| % Glomerulonephritis | 10.2 | 9.9 | 9.6 | 13.5 |
| % Nephrosclerosis | 16.3 | 16.5 | 18.7 | 5.6 |
| % Other | 11.8 | 11.3 | 11.3 | 15.0 |
| BMI (SD) (kg/m2) | 28.13 (5.64) | 28.67 (5.61) | 28.00 (5.53) | 27.76 (6.14) |
| eGFR* (SD) (MDRD) | 24.95 (9.80) | 38.18 (7.19) | 22.50 (4.21) | 11.78 (2.38) |
| MAP† (SD) (mm Hg) | 97.27 (12.70) | 95.75 (12.44) | 97.31 (12.67) | 99.87 (12.96) |
| Protein-restricted diet (%) | 4.7 | 0.8 | 4.0 | 14.4 |
| Diuretics use (%) | 72.5 | 66.8 | 75.0 | 71.7 |
| Statin use (%) | 50.2 | 57.7 | 48.4 | 44.2 |
| UA lowering drugs (%) | 39.3 | 40.5 | 39.6 | 36.1 |
| Diabetes Mellitus (%) | 36.0 | 36.4 | 36.9 | 31.1 |
| Arrhythmia (%) | 19.3 | 22.3 | 19.4 | 13.2 |
| CVD (%) | 14.5 | 16.3 | 13.7 | 15.0 |
| IHD (%) | 26.0 | 26.5 | 26.4 | 23.5 |
| Hypertension (%) | 72.9 | 77.8 | 71.4 | 70.7 |
| Pulmonary disease (%) | 11.4 | 13.9 | 10.7 | 10.0 |
| CHF (%) | 21.2 | 22.3 | 21.9 | 15.8 |
| Gout (%) | 10.0 | 11.5 | 10.2 | 6.5 |
| RRT initiation (n) | 530 | 21 | 324 | 190 |
| RRT modality | ||||
| %HD | 311 | 10 | 192 | 109 |
| %PD | 175 | 7 | 97 | 71 |
| %Tx | 44 | 4 | 30 | 10 |
| . | CKD III–V (n = 2466) . | CKD III (n = 618) . | CKD IV (n = 1507) . | CKD V (n = 341) . |
|---|---|---|---|---|
| UA (SD) (mg/dL) | 7.81 (1.98) | 7.68 (1.95) | 7.94 (1.97) | 7.47 (2.02) |
| Age (SD) (years) | 68.98 (13.59) | 67.39 (13.67) | 69.85 (13.32) | 68.00 (14.28) |
| Sex (% male) | 65.4 | 27.3 | 36.1 | 41.1 |
| PKD | ||||
| % Diabetes | 17.7 | 15.7 | 18.8 | 16.4 |
| % Glomerulonephritis | 10.2 | 9.9 | 9.6 | 13.5 |
| % Nephrosclerosis | 16.3 | 16.5 | 18.7 | 5.6 |
| % Other | 11.8 | 11.3 | 11.3 | 15.0 |
| BMI (SD) (kg/m2) | 28.13 (5.64) | 28.67 (5.61) | 28.00 (5.53) | 27.76 (6.14) |
| eGFR* (SD) (MDRD) | 24.95 (9.80) | 38.18 (7.19) | 22.50 (4.21) | 11.78 (2.38) |
| MAP† (SD) (mm Hg) | 97.27 (12.70) | 95.75 (12.44) | 97.31 (12.67) | 99.87 (12.96) |
| Protein-restricted diet (%) | 4.7 | 0.8 | 4.0 | 14.4 |
| Diuretics use (%) | 72.5 | 66.8 | 75.0 | 71.7 |
| Statin use (%) | 50.2 | 57.7 | 48.4 | 44.2 |
| UA lowering drugs (%) | 39.3 | 40.5 | 39.6 | 36.1 |
| Diabetes Mellitus (%) | 36.0 | 36.4 | 36.9 | 31.1 |
| Arrhythmia (%) | 19.3 | 22.3 | 19.4 | 13.2 |
| CVD (%) | 14.5 | 16.3 | 13.7 | 15.0 |
| IHD (%) | 26.0 | 26.5 | 26.4 | 23.5 |
| Hypertension (%) | 72.9 | 77.8 | 71.4 | 70.7 |
| Pulmonary disease (%) | 11.4 | 13.9 | 10.7 | 10.0 |
| CHF (%) | 21.2 | 22.3 | 21.9 | 15.8 |
| Gout (%) | 10.0 | 11.5 | 10.2 | 6.5 |
| RRT initiation (n) | 530 | 21 | 324 | 190 |
| RRT modality | ||||
| %HD | 311 | 10 | 192 | 109 |
| %PD | 175 | 7 | 97 | 71 |
| %Tx | 44 | 4 | 30 | 10 |
PKD, primary kidney disease.
*In ml/min/1.73 m2.
†Calculated as [(2/3*Systolic blood pressure) + (1/3*diastolic blood pressure)/2].
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
